KRYS Under Heavy Short Pressure
Krystal Biotech (KRYS) has been flagged for 77 consecutive days on the FINRA threshold list, highlighting a persistent and aggressive short position. With 13.7% of the float currently shorted and a days-to-cover ratio of 10.3, the stock is exhibiting classic signs of a crowded short trade. Despite the 0.3% borrow fee, the sheer volume of short interest relative to the float suggests that any positive catalyst could trigger a significant short squeeze. Traders should monitor the stock for increased volatility and potential borrow fee spikes as the market continues to test the resolve of the short sellers.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.